Marinomed Biotech AG | WebDisclosure

BRIEF

published on 10/06/2025 at 15:01, 1 month 29 days ago

Marinomed Biotech AG explore des alternatives stratégiques pour la plateforme Marinosolv

Marinomed Biotech Innovation Biotechnologique Plateforme Marinosolv Options Stratégiques Partenariats En Santé
BRIEF

published on 10/06/2025 at 15:01, 1 month 29 days ago

Marinomed Biotech AG Explores Strategic Alternatives for Marinosolv Platform

Strategic Options Marinomed Biotech Biotech Innovation Marinosolv Platform Health Partnerships
PRESS RELEASE

published on 10/06/2025 at 14:56, 1 month 29 days ago

EQS-Adhoc: Marinomed Biotech AG begins reviewing strategic options for the Marinosolv platform
Marinomed Biotech AG initiates strategic review of Marinosolv platform following successful capital measures. Evaluation may include partnerships for Budesolv and Tacrosolv projects

Strategic Partnerships Marinomed Biotech AG Strategic Review Marinosolv Platform Capital Measures
BRIEF

published on 10/01/2025 at 12:23, 2 months 3 days ago

Marinomed Biotech AG : First Berlin Equity réitère sa recommandation d'achat

Résultats Financiers Augmentation De Capital Marinomed Biotech AG Recommandation D'achat Accords De Licence
BRIEF

published on 10/01/2025 at 12:23, 2 months 3 days ago

Marinomed Biotech AG: First Berlin Equity Reiterates Buy Rating

Financial Results Buy Recommendation Capital Increase Marinomed Biotech AG Licensing Deals
PRESS RELEASE

published on 10/01/2025 at 12:18, 2 months 3 days ago

Original-Research: Marinomed Biotech AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research reaffirmed a Buy rating and EUR 50.00 price target for Marinomed Biotech AG. H1 results were in line with expectations, with nearly tripled sales and positive AEBITDA amid strategic financial moves

First Berlin Equity Research BUY Rating Marinomed Biotech AG H1 Results EUR 50.00 Price Target
BRIEF

published on 09/17/2025 at 13:53, 2 months 17 days ago

Marinomed Biotech AG annonce une croissance significative au premier semestre 2025

Résultats Financiers Augmentation Des Revenus Croissance Du Résultat D'exploitation (EBIT) Croissance De La Biotechnologie Mesures De Capital
BRIEF

published on 09/17/2025 at 13:53, 2 months 17 days ago

Marinomed Biotech AG Reports Significant Growth in H1 2025

Financial Results Revenue Increase EBIT Growth Capital Measures Biotech Growth
PRESS RELEASE

published on 09/17/2025 at 13:48, 2 months 17 days ago

Marinomed Biotech AG announces results for the first half year of 2025
Marinomed Biotech AG reports strong financial results for the first half of 2025, with revenues of EUR 7.2 million and EBIT of EUR 21.0 million. The company secured financing through capital measures

Revenues Financial Results EBIT Marinomed Biotech AG Capital Measures
BRIEF

published on 09/16/2025 at 15:27, 2 months 18 days ago

Marinomed Biotech AG Announces Capital Increase

Investment Biotech Industry Capital Increase Share Issuance Marinomed Biotech AG

Published on 12/05/2025 at 02:35, 6 hours 43 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 6 hours 48 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 8 hours 18 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 13 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 10 hours 18 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

Published on 12/05/2025 at 09:05, 13 minutes ago

Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 09:00, 17 minutes ago

Original-Research: DEMIRE AG (von NuWays AG): BUY
Published on 12/05/2025 at 09:00, 18 minutes ago

SPECTRIS PLC - Removal
Published on 12/05/2025 at 09:00, 18 minutes ago

Official List Notice
Published on 12/05/2025 at 09:00, 18 minutes ago

Petershill Partners plc - Removal

View all EQS

Published on 12/05/2025 at 08:45, 33 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 33 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 35 minutes ago

ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 15 hours 3 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 15 hours 18 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025

View all LES ECHOS COMFI WIRE

News